Theravance Biopharma (TBPH) Stock Chart & Stock Price History → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free TBPH Stock Alerts $8.44 -0.55 (-6.12%) (As of 05:14 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Theravance Biopharma Stock Price Performance5 Day Performance-5.25%1 Month Performance-3.46%3 Month Performance-11.36%6 Month Performance-6.88%Year-To-Date Performance-22.95%1 Year Performance-20.04% Receive TBPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & Company#1 election stockI’ve found the number one company to buy… Before either Trump or Biden wins in November. It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power. For the full story, click here. TBPH Stock Chart for Tuesday, April, 30, 2024 TBPH Chart by TradingView Theravance Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2024$9.12$8.99-1.43%$9.22$8.95293,236 shs$436.55 million04/26/2024$9.14$9.12-0.22%$9.27$9.06263,498 shs$442.87 million04/25/2024$9.17$9.14-0.33%$9.33$9.00387,247 shs$443.84 million04/24/2024$9.22$9.17-0.54%$9.26$9.05297,148 shs$445.30 million04/23/2024$9.46$9.22-2.54%$9.61$9.19335,578 shs$447.72 million04/22/2024$9.34$9.46+1.28%$9.47$9.25309,737 shs$459.38 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/19/2024$9.20$9.34+1.52%$9.38$9.02433,019 shs$453.55 million04/18/2024$9.52$9.20-3.36%$9.52$9.15362,260 shs$446.75 million04/17/2024$9.69$9.52-1.75%$9.85$9.49307,877 shs$462.29 million04/16/2024$9.92$9.69-2.32%$9.88$9.59472,501 shs$470.55 million04/15/2024$9.61$9.92+3.23%$9.98$9.49517,509 shs$481.72 million04/12/2024$8.93$9.61+7.61%$10.44$9.45777,062 shs$466.66 million04/11/2024$9.54$8.93-6.39%$9.61$8.83472,613 shs$433.64 million04/10/2024$9.48$9.54+0.63%$9.55$9.18468,680 shs$463.26 million04/09/2024$9.47$9.48+0.11%$9.63$9.30507,605 shs$456.65 million04/08/2024$9.31$9.47+1.72%$9.51$9.21371,772 shs$456.17 million04/05/2024$9.14$9.31+1.86%$9.33$9.05346,333 shs$448.46 million04/04/2024$9.29$9.14-1.61%$9.42$9.05438,866 shs$440.27 million04/03/2024$9.10$9.29+2.09%$9.32$9.00476,529 shs$447.50 million04/02/2024$9.03$9.10+0.78%$9.12$8.79458,264 shs$438.35 million04/01/2024$8.97$9.03+0.67%$9.04$8.75317,719 shs$434.98 million03/29/2024$8.97$8.97$9.00$8.77401,710 shs$432.09 million03/28/2024$9.01$8.97-0.44%$9.00$8.77401,710 shs$432.09 million03/27/2024$8.82$9.01+2.15%$9.02$8.79320,008 shs$434.01 million03/26/2024$8.76$8.82+0.68%$8.95$8.75296,174 shs$424.86 million03/25/2024$8.92$8.76-1.79%$9.09$8.66365,377 shs$421.93 million03/22/2024$8.96$8.92-0.45%$8.98$8.83303,569 shs$429.68 million03/21/2024$9.01$8.96-0.55%$9.08$8.80364,078 shs$431.60 million03/20/2024$8.85$9.01+1.81%$9.03$8.70365,823 shs$434.01 million03/19/2024$8.65$8.85+2.31%$8.91$8.57495,636 shs$426.30 million03/18/2024$8.64$8.65+0.12%$8.80$8.54458,899 shs$416.67 million03/15/2024$8.61$8.64+0.35%$8.84$8.50899,346 shs$416.19 million03/14/2024$8.80$8.61-2.16%$9.26$8.55449,646 shs$414.74 million03/13/2024$8.52$8.80+3.29%$8.81$8.51358,683 shs$423.90 million03/12/2024$8.57$8.52-0.58%$8.65$8.45214,305 shs$410.41 million03/11/2024$8.62$8.57-0.58%$8.68$8.42272,101 shs$412.77 million03/08/2024$8.69$8.62-0.81%$8.85$8.52153,037 shs$415.23 million03/07/2024$8.74$8.69-0.57%$8.78$8.59262,859 shs$418.60 million03/06/2024$8.67$8.74+0.81%$8.83$8.68267,079 shs$421.01 million03/05/2024$9.10$8.67-4.73%$9.21$8.63309,276 shs$431.77 millionTrump’s last act as President (Ad)You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here.03/04/2024$9.44$9.10-3.60%$9.44$9.09388,533 shs$453.18 million03/01/2024$9.47$9.44-0.32%$9.65$9.35242,748 shs$470.11 million02/29/2024$9.40$9.47+0.74%$9.66$9.44380,292 shs$471.61 million02/28/2024$9.69$9.40-2.99%$9.79$9.33263,644 shs$468.12 million02/27/2024$9.23$9.69+4.98%$10.11$9.03532,249 shs$482.56 million02/26/2024$8.98$9.23+2.78%$9.24$8.91225,345 shs$459.64 million02/23/2024$8.68$8.98+3.52%$8.98$8.54420,407 shs$447.20 million02/22/2024$8.76$8.68-0.97%$8.79$8.61280,433 shs$432.02 million02/21/2024$8.92$8.76-1.79%$8.98$8.63294,568 shs$436.25 million02/20/2024$8.80$8.92+1.36%$9.02$8.73334,650 shs$444.22 million02/19/2024$8.80$8.80$8.87$8.56346,900 shs$438.24 million02/16/2024$8.67$8.80+1.50%$8.87$8.56344,339 shs$438.22 million02/15/2024$8.46$8.67+2.48%$8.74$8.48273,752 shs$431.77 million02/14/2024$8.35$8.46+1.32%$8.49$8.29256,202 shs$421.31 million02/13/2024$8.58$8.35-2.68%$8.50$8.26471,781 shs$415.83 million02/12/2024$8.58$8.58$8.66$8.43257,557 shs$427.28 million02/09/2024$8.22$8.58+4.38%$8.60$8.28294,614 shs$427.28 million02/08/2024$8.50$8.22-3.29%$8.70$8.22734,240 shs$409.36 million02/07/2024$8.82$8.50-3.63%$8.86$8.50356,057 shs$423.30 million02/06/2024$8.85$8.82-0.34%$8.92$8.72274,296 shs$439.24 million02/05/2024$8.90$8.85-0.56%$8.91$8.64362,890 shs$440.73 million02/02/2024$9.16$8.90-2.84%$9.10$8.78361,055 shs$443.20 million02/01/2024$9.48$9.16-3.38%$9.47$9.07362,515 shs$456.17 million01/31/2024$9.77$9.48-2.97%$9.86$9.48237,728 shs$472.10 million01/30/2024$10.03$9.77-2.59%$10.03$9.73281,488 shs$486.55 million01/29/2024$9.91$10.03+1.21%$10.04$9.81190,640 shs$499.49 million Related Companies: STTK Stock Price Chart SLRN Stock Price Chart IGMS Stock Price Chart TVTX Stock Price Chart ANL Stock Price Chart FULC Stock Price Chart TRDA Stock Price Chart APLT Stock Price Chart KALV Stock Price Chart CDMO Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.